EFMC-ISMC 2022

Flash Poster Presentations

Flash Poster Presentation Session 1

KOLOCOURIS Antonios UNIVERSITY OF ATHENS FP01 NOVEL PYRAZOLO[3,4-C]PYRIDINE ANTAGONISTS WITH NANOMOLAR AFFINITY FOR A1 / A3 ADENOSINE RECEPTORS: BINDING KINETICS AND EXPLORATION OF THEIR BINDING PROFILE USING MUTAGENESIS EXPERIMENTS, MD SIMULATIONS AND  TI/MD CALCULATIONS
BHELA  Irene Preet UNIVERSITY OF PIEMONTE FP02 A STRAIGHTFORWARD SYNTHESIS OF PROTACS THROUGH MULTICOMPONENT REACTIONS 
BOURGEAIS Mathieu UNIVERSITY OF BORDEAUX FP03 BIFUNCTIONAL CHEMICAL TOOLS FOR THE TARGETED DEGRADATION OF FURIN
NOCE Beatrice UNIVERSITY OF ROME FP04 NOVEL PYRIDINE-BASED HYDROXAMATES AND 2'-AMINOANILIDES AS HISTONE DEACETYLASE INHIBITORS: BIOCHEMICAL PROFILE AND ANTICANCER ACTIVITY
GRECO Francesco Aleksy GOETHE UNIVERSITY FRANKFURT FP05 CHEMICAL EXPLORATION OF THE ORTHOSTERIC AND ALLOSTERIC POCKETS OF DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5 (MAP2K5/MEK5) BY SMALL MOLECULES
HUANG Rong PURDUE UNIVERSITY FP06 RATIONAL DEVELOPMENT OF POTENT AND SPECIFIC INHIBITORS FOR METHYLTRANSFERASES 
DRAKOPOULOS Antonios UNIVERSITY OF GOTHENBURG FP07 EXPLORING THE MODE OF ACTION, THERMODYNAMIC PROFILE AND NUCLEOPHILE SELECTIVITY OF LABELLING WARHEADS FOR BRUTON'S TYROSINE KINASE
LOI Elena UNIVERSITY OF LJUBLJANA FP08 THE QUEST FOR THE FIRST POTENT IN VIVO ACTING OGT INHIBITOR
PROJ Matic UNIVERSITY OF LJUBLJANA FP09 REDOX ACTIVE OR THIOL REACTIVE? OPTIMIZATION OF RAPID SCREENS TO IDENTIFY LESS EVIDENT NUISANCE COMPOUNDS
KHEMAISSA Sonia SORBONNE UNIVERSITY FP10 DESIGN AND INTERNALIZATION PROPERTIES OF CHIMERIC CPP-GAG BINDING PEPTIDES

 

Flash Poster Presentation Session 2

BERABEZ Rayan UNIVERSITY OF ORLEANS FP11 SYNTHESIS AND PRECLINICAL VALIDATION OF LIMKS INHIBITORS: PROMISING DRUGS FOR OSTEOSARCOMA TREATMENT?
PAPANASTASIOU Ioannis NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS FP12 AN OVERVIEW OF THE ANTITRYPANOSOMAL PROFILE OF ADAMANTANE SCAFFOLDS
RICCIO Alessandra UNIVERSITY OF PERUGIA FP13 BEYOND CONVENTIONAL ANTI-CANCER AGENTS IN IMMUNOTHERAPY: HOW A TUMOR MICROENVIRONMENT LIMITATION COULD BE TURNED INTO AN ADVANTAGE
ESPELAND Ludvik UNIVERSITY OF BERGEN FP14  TARGETING A PSEUDOMONAS AERUGINOSA beta-KETOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE WITH COVALENT INHIBITORS INSPIRED BY CERULENIN
GANTER  Benedikt  UNIVERSITY OF HAMBURG FP15 SYNTHESIS OF MODIFIED T-1106-5´-TRIPHOSPHATES AS POTENTIAL INHIBITOR OF THE SARS-COV-2 RDRP
MARTIN SERRANO ORTIZ Angela UNIVERSITY OF GRENOBLE-ALPES FP16 PRECLINICAL EVALUATION OF ANTIBODY RECRUITING GLYCODENDRIMERS (ARGs) FOR CANCER THERAPHY
ZOLLO Michael TU MUNICH FP17 NEW CHEMOPROTEOMIC TECHNOLOGIES AND CHEMICAL MODALITIES FOR ANTIBIOTIC DISCOVERY
BRAUN Maria SPECS FP18  DISCOVERY AND OPTIMIZATION OF NOVEL ANTI-INFECTIVES TARGETING ISPE USING PROTEIN-TEMPLATED SYNTHESIS 
UGOLINI Alessandra ITALIAN INSTITUTE OF TECHNOLOGY FP19 BACTERICIDAL AUTOPHAGY INHIBITORS TO TREAT RECURRENT INFECTIONS AND CANCER 
KOVACHKA Sandra UNIVERSITY OF CÔTE D'AZUR FP20 PANICEIN A HYDROQUINONE AND ANALOGS OVERCOME CHEMOTHERAPY RESISTANCE IN CANCER CELL


Flash Poster Session 1 (FP01-FP10)

  • FP01    KOLOCOURIS    Antonios    UNIVERSITY OF ATHENS   
    NOVEL PYRAZOLO[3,4-C]PYRIDINE ANTAGONISTS WITH NANOMOLAR AFFINITY FOR A1 / A3 ADENOSINE RECEPTORS: BINDING KINETICS AND EXPLORATION OF THEIR BINDING PROFILE USING MUTAGENESIS EXPERIMENTS, MD SIMULATIONS AND  TI/MD CALCULATIONS

  • FP02    BHELA     Irene Preet    UNIVERSITY OF PIEMONTE   
    A STRAIGHTFORWARD SYNTHESIS OF PROTACS THROUGH MULTICOMPONENT REACTIONS

  • FP03    BOURGEAIS    Mathieu    UNIVERSITY OF BORDEAUX   
    BIFUNCTIONAL CHEMICAL TOOLS FOR THE TARGETED DEGRADATION OF FURIN

  • FP04    NOCE    Beatrice    UNIVERSITY OF ROME   
    NOVEL PYRIDINE-BASED HYDROXAMATES AND 2'-AMINOANILIDES AS HISTONE DEACETYLASE INHIBITORS: BIOCHEMICAL PROFILE AND ANTICANCER ACTIVITY

  • FP05    GRECO    Francesco Aleksy    GOETHE UNIVERSITY FRANKFURT   
    CHEMICAL EXPLORATION OF THE ORTHOSTERIC AND ALLOSTERIC POCKETS OF DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5 (MAP2K5/MEK5) BY SMALL MOLECULES

  • FP06    HUANG    Rong    PURDUE UNIVERSITY   
    RATIONAL DEVELOPMENT OF POTENT AND SPECIFIC INHIBITORS FOR METHYLTRANSFERASES

  • FP07    DRAKOPOULOS    Antonios    UNIVERSITY OF GOTHENBURG   
    EXPLORING THE MODE OF ACTION, THERMODYNAMIC PROFILE AND NUCLEOPHILE SELECTIVITY OF LABELLING WARHEADS FOR BRUTON'S TYROSINE KINASE

  • FP08    LOI    Elena    UNIVERSITY OF LJUBLJANA   
    THE QUEST FOR THE FIRST POTENT IN VIVO ACTING OGT INHIBITOR

  • FP09    PROJ    Matic    UNIVERSITY OF LJUBLJANA   
    REDOX ACTIVE OR THIOL REACTIVE? OPTIMIZATION OF RAPID SCREENS TO IDENTIFY LESS EVIDENT NUISANCE COMPOUNDS

  • FP10    KHEMAISSA    Sonia    SORBONNE UNIVERSITY   
    DESIGN AND INTERNALIZATION PROPERTIES OF CHIMERIC CPP-GAG BINDING PEPTIDES


Flash Poster Session 2 (FP11-FP20)

  • FP11    BERABEZ    Rayan    UNIVERSITY OF ORLEANS   
    SYNTHESIS AND PRECLINICAL VALIDATION OF LIMKS INHIBITORS: PROMISING DRUGS FOR OSTEOSARCOMA TREATMENT?

  • FP12    PAPANASTASIOU    Ioannis    UNIVERSITY OF ATHENS   
    AN OVERVIEW OF THE ANTITRYPANOSOMAL PROFILE OF ADAMANTANE SCAFFOLDS

  • FP13    RICCIO    Alessandra    UNIVERSITY OF PERUGIA   
    BEYOND CONVENTIONAL ANTI-CANCER AGENTS IN IMMUNOTHERAPY: HOW A TUMOR MICROENVIRONMENT LIMITATION COULD BE TURNED INTO AN ADVANTAGE

  • FP14     ESPELAND    Ludvik    UNIVERSITY OF BERGEN   
    TARGETING A PSEUDOMONAS AERUGINOSA beta-KETOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE WITH COVALENT INHIBITORS INSPIRED BY CERULENIN

  • FP15    GANTER     Benedikt     UNIVERSITY OF HAMBURG   
    SYNTHESIS OF MODIFIED T-1106-5´-TRIPHOSPHATES AS POTENTIAL INHIBITOR OF THE SARS-COV-2 RDRP

  • FP16    MARTIN SERRANO ORTIZ    Angela    UNIVERSITY OF GRENOBLE-ALPES   
    PRECLINICAL EVALUATION OF ANTIBODY RECRUITING GLYCODENDRIMERS (ARGs) FOR CANCER THERAPHY

  • FP17    ZOLLO    Michael    TU MUNICH   
    NEW CHEMOPROTEOMIC TECHNOLOGIES AND CHEMICAL MODALITIES FOR ANTIBIOTIC DISCOVERY

  • FP18     BRAUN    Maria    SPECS   
    DISCOVERY AND OPTIMIZATION OF NOVEL ANTI-INFECTIVES TARGETING ISPE USING PROTEIN-TEMPLATED SYNTHESIS

  • FP19    UGOLINI    Alessandra    ITALIAN INSTITUTE OF TECHNOLOGY   
    BACTERICIDAL AUTOPHAGY INHIBITORS TO TREAT RECURRENT INFECTIONS AND CANCER

  • FP20    KOVACHKA    Sandra    UNIVERSITY OF CÔTE D'AZUR   
    PANICEIN A HYDROQUINONE AND ANALOGS OVERCOME CHEMOTHERAPY RESISTANCE IN CANCER CELL



Flash Poster Session 3 (FP21-FP30)

  • FP21    TARKHANOVA    Olga    CHEMSPACE   
    ULTRA-LARGE CHEMICAL SPACES: APPROACHES TO BUILD AND EXPLORE

  • FP22     BARTOS    Piia    UNIVERSITY OF EASTERN FINLAND   
    THE DARK SIDE OF MOLECULAR DYNAMICS SIMULATIONS: RNA-PROTEIN COMPLEXES

  • FP23    DEGOTTE    Gilles    UNIVERSITY OF GRENOBLE-ALPES   
    DEVELOPMENT OF ENCODED COMBINATORIAL CHEMISTRY FOR THE IDENTIFICATION OF SPECIFIC LIGANDS OF G-QUADRUPLEX DNA STRUCTURES

  • FP24     COTMAN    Andrej Emanuel    UNIVERSITY OF LJUBLJANA   
    CHIRAL INDANS VIA DYNAMIC KINETIC RESOLUTION: THREE-DIMENSIONAL BUILDING BLOCKS AND NATURAL PRODUCTS

  • FP25    DINH    Le Vi    MONASH UNIVERSITY   
    DEVELOPMENT OF CALCIUM-SENSING RECEPTOR AGO-POSITIVE ALLOSTERIC MODULATORS, AC265347 DERIVATIVES, FOR THE TREATMENT OF HYPERPARATHYROIDISM AND RELATED DISORDERS

  • FP26    COLSON    Eloïse    UNIVERSITY OF BERNE   
    EXPANDING THE MEDICINAL CHEMISTRY SYNTHETIC TOOLBOX WITH A RADICAL [3+3]-ANNULATION TOWARDS TROPANE AND RELATED ALKALOID SKELETONS

  • FP27    MATVIYUK    Tatiana    ENAMINE   
    UNEXPECTED ISOMERIZATION OF OXETANE-CARBOXYLIC ACIDS

  • FP28    MORGAN    Barry    UNIVERSITY OF TEXAS   
    DOES DNA-ENCODED LIBRARY TECHNOLOGY PROVIDE "NOVELTY"?

  • FP29    MAKARA    Gergely    CHEMPASS   
    AI-ASSISTED GENERATIVE DESIGN OF SYNTHETICALLY FEASIBLE CHEMICAL SPACE FOR LEAD OPTIMIZATION

  • FP30    REP    Valentina    UNIVERSITY OF ZAGREB   
    NOVEL REVERSED AMIDINE BENZOTHIAZOLES: DESIGN, SYNTHESIS, ANTITRYPANOSOMAL ACTIVITY AND ADME PROFILING

Flash Poster Session 4 (FP31-FP40)

  • FP31    PALAFERRI    Leonardo    UZH   
    A RATIONAL AND SYSTEMATIC APPROACH TO PROTACS DEVELOPMENT: IDENTIFICATION OF CBP/EP300 DEGRADERS

  • FP32    CALZAFERRI    Francesco    CNRS   
    NOVEL STRATEGIES TO STUDY DNA METHYLATION IN HAEMATOLOGICAL CANCERS

  • FP33    MAPLE    Hannah    BIO-TECHNE   
    VALIDATING TARGETS FOR TARGETED PROTEIN DEGRADATION USING DTAG ? A COMPREHENSIVE WORKFLOW SOLUTION

  • FP34    GRISEL    Clément    CNRS  
    DESIGN OF CHEMICAL PROBES DERIVED FROM SCHWEINFURTHINS TO HIJACK OSBP

  • FP35    RAMOS LLORCA    Alba    UANTWERP   
    ACTIVITY-BASED PROBES TARGETING TRYPSIN-LIKE SERINE PROTEASES FOR TARGET AND BIOMARKER DISCOVERY

  • FP36    CORNER    Thomas    UNIVERSITY OF OXFORD   
    STRUCTURE-GUIDED OPTIMISATION OF SMALL-MOLECULE INHIBITORS OF THE HUMAN 2-OXOGLUTARATE-DEPENDENT OXYGENASE FACTOR INHIBITING HYPOXIA-INDUCIBLE FACTOR

  • FP37    CHIEW    Beatrice    UNIVERSITY OF NEWCASTLE   
    DESIGN IN THE DARK - ILLUMINATING THE DRUGGABILITY OF 53BP1 FOR BRCA-1 BREAST CANCER

  • FP38    BORLANDELLI    Valentina    LEIDEN UNIVERSITY   
    CYCLITOLS AS COVALENT INHIBITORS AND ACTIVITY-BASED PROBES FOR ?-D-GLUCURONIDASE AGAINST METABOLIC DRUG REACTIVATION AND CANCER PROGRESSION

  • FP39    VAN WIER    Suzanne    UNIVERSITY OF EAST ANGLIA   
    REMOVING CANCER'S IMMORTALITY: TARGETING TELOMERASE

  • FP40    VINAGREIRO    Carolina    LEIBNIZ INSTITUTE   
    ACTIVATABLE LUMINESCENT LANTHANOID PROBES FOR THE DETECTION OF VIRAL AND BACTERIAL INFECTIONS


Flash Poster Session 5 (FP41-FP50)

  • FP41    PROVENZANI    Riccardo    UNIVERSITY OF HELSINKI   
    MEMBRANE MOLECULAR DYNAMICS-ADJUVATED DESIGN AND SYNTHESIS OF MULTISUBSTITUTED PYRIDINES AS NOVEL PKC-TARGETED AGONISTS

  • FP42    ZWERGEL    Clemens    UNIVERSITY OF ROME LA SAPIENZA   
    NOVEL SELENIUM CONTAING COMPOUNDS AS A PROMISE IN CANCER THERAPY? ABCB1 EFFLUX PUMP MODULATING AGENTS WITH CYTOTOXIC AND ANTIPROLIFERATIVE ACTIONS IN RESISTANT T-LYMPHOMA

  • FP43    SHCHEHOLEVA    Iryna    UNIVERSITY OF COTE D'AZUR   
    ONCOGENIC MICRORNA INHIBITION BY SMALL MOLECULES: FRAGMENT-BASED DE NOVO LIGAND DESIGN AND SYNTHESIS

  • FP44    BOFFEY    Helen    ALBORADA DRUG DISCOVERY INSTITUTE   
    DEVELOPMENT OF SELECTIVE, BRAIN PENETRANT PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE GAMMA INHIBITORS WITH CONTRASTING BINDING MODES

  • FP45    NOZAL GARCIA    Vanesa    CIB - CSIC   
    RESCUING MOTOR NEURON DEGENERATION USING NOVEL MLK3 MODULATORS

  • FP46    KRAUPNER    Nicolas    UNIVERSITY OF LILLE   
    IDENTIFICATION AND HIT MODULATION OF INDOLE-BASED ACTIVATORS OF THE INSULIN DEGRADING ENZYME

  • FP47     KEIFF    Francois    LEIBNIZ INSITUTE   
    MODULATION OF THE MEISENHEIMER COMPLEX METABOLISM OF ANTIMYCOBACTERIAL BENZOTHIAZINONES

  • FP48    OTAVA    Tomáš    IOCB PRAGUE   
    DESIGN AND SYNTHESIS OF S-ADENOSYLHOMOCYSTEINE ANALOGUES AS NANOMOLAR INHIBITORS OF SARS-COV-2 NSP14 METHYLTRANSFERASE

  • FP49    LAPHOOKHIEO    Surat    MAE FAH LUANG UNIVERSITY   
    ALPHA-GLUCOSIDASE INHIBITORY ACTIVITY OF COMPOUNDS ISOLATED FROM FOUR ANNONACEAE PLANTS: DASYMASCHALON DASYMASCHALUM, DESMOS COCHINCHINESNSIS, POLYALTHIA CINNAMOMEA, AND TRIVALVARIA MACROPHYLLA

  • FP50    DROP    Marcin    JAGIELLONIAN UNIVERSITY   
    NOVEL 5-HT6R NEUTRAL ANTAGONISTS DERIVED FROM 2-ARYLPYRROLE: CONTRIBUTION OF AGONIST-ACTIVATED STATES OF THE RECEPTOR TO NEUROTOXICITY


Flash Poster Session 6 (FP51-FP60)

  • FP51    COLCHON-PIERNA    Esther    UNIVERSITY OF SANTIAGO DE COMPOSTELA   
    FREE LABELLING PLATFORM TO DETERMINE DRUG BINDING TO PROTEINS

  • FP52    JOCH    Melanie    LEIBNIZ INSTITUTE   
    A CELL-BASED METABOLIC ASSAY FOR HYDRIDE MEISENHEIMER FORMATION ASSESSMENT TO GUIDE LEAD OPTIMIZATION OF NEXT-GENERATION ANTITUBERCULAR BENZOTHIAZINONES

  • FP53    GENTILINI    Emilie    UNIVERSITY OF CÔTE D'AZUR   
    NOVEL METHODOLOGIES FOR THE SYNTHESIS OF POLYCYCLIC DERIVATIVES USING GOLD AND CARBOPHILIC METAL CATALYSIS

  • FP54    POCHET    Lionel    UNAMUR   
    TOWARDS NEW FXIIa INHIBITORS BY APPLICATION OF A FRAGMENT-BASED LEAD DISCOVERY APPROACH AND AFFINITY CAPILLARY ELECTROPHORESIS SCREENING ASSAY

  • FP55    NOWICKI    Krzysztof    WARSAW UNIVERSITY OF TECHNOLOGY     
    THE USE OF THIOL-FUNCTIONALIZED BENZOSILOXABOROLES FOR ACHIEVING DIVERSE SUBSTITUTION PATTERNS - BIOLOGICAL EVALUATION OF NOVEL PROMISING ANTIBACTERIAL AGENTS

  • FP56    LEBERECHT    Christoph    PHARMAI   
    GENERATION OF FOCUSED LIBRARIES: AI-POWERED REDUCTION OF LARGE COMPOUND LIBRARIES LEADS TO THE DISCOVERY OF NOVEL INHIBITORS OF SIRTUIN-1

  • FP57    MULLIRI    Kleni    UNIVERSITY OF BERN   
    SAR OF TRIQUINAZINE, A CLASS OF POTENT JANUS KINASE INHIBITORS

  • FP58    TARDIA    Piero     CHARLES RIVER LABORATORIES   
    DISCOVERY OF A NOVEL CLASS OF D-AMINO ACID OXIDASE INHIBITORS USING THE SCHRÖDINGER COMPUTATIONAL PLATFORM

  • FP59    SAN    Carine    CNAM   
    OPTIMIZATION OF A SYNTHETIC STEP USING A DESIGN OF EXPERIMENTS APPROACH: APPLICATION TO A LATE-STAGE RADIOLABELING METHOD BY ALUMINIUM-[18F]FLUORIDE COORDINATION

  • FP60    SCHEIBELBERGER    Lukas    UNIVERSITY OF VIENNA   
    SYNTHESIS OF 4-DEOXY-4-FLUORO-D-SEDOHEPTULOSE AND AN APPROACH FOR ITS FLUORINE-18 LABELED ANALOGUE


Organised by

With the Support of

Platinum Sponsor

Gold Sponsors

Silver Sponsor

Bronze Sponsors

Copyright 2024 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys